Synthesis and neuromuscular blocking activity of 16β-N-methylpiperazino steroidal derivatives

European Journal of Medicinal Chemistry

Volumn 37, Issue 11, 2003, Pages 901-908

  Jindal, Dharam Paul ^a   Piplani, Poonam ^a   Fajrak, H ^b   Prior, C ^b   Marshall, Ian G ^b  

^a PANJAB UNIVERSITY   (India)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bisquaternary; Chick biventer; D Tubocurarine; N Methylpiperazine; Neostigmine; Non depolarising

Indexed keywords

16BETA N METHYLPIPERAZINO 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA OL DIMETHIODIDE; 16BETA N METHYLPIPERAZINO 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA YLACETATE DIMETHIODIDE; DPJ 494; DPJ 496; GANGLION BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; PIPECURONIUM BROMIDE; PIPERAZINE DERIVATIVE; STEROID; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG; QUATERNARY AMMONIUM DERIVATIVE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CHICKEN; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; ANIMAL; DRUG EFFECT; GANGLION; HEMODYNAMICS; MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; CATS; CHICKENS; GANGLIA; HEMODYNAMIC PROCESSES; MUSCLE CONTRACTION; NEUROMUSCULAR BLOCKING AGENTS; QUATERNARY AMMONIUM COMPOUNDS; STEROIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 1842832482     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(02)01413-7     Document Type: Article

References (28)

1. Stenlake J.B. Ellis G.P., West G.B., Progress in Medicinal Chemistry. 16:1979;257-286 Elsevier, Amsterdam.
2. Gennaro A.R., 20th ed. Remington: The Science and Practice of Pharmacy. II:2001;1333-1343 Lippincott Williams and Wilkins, A Wolters Kluwer Company, Philadelphia.
3. Young R.R. Neurology. 44:(Suppl. 9):1994;S12-S20.
4. Koko C., Ward A.B. Br. J. Hosp. Med. 58:1997;400-405.
5. Elliot J.M., Bion J.F. Acta Anaesthesiol. Scand. 39:(Suppl. 106):1995;70-82.
6. McGee S.R. Arch. Intern. Med. 150:1990;511-518.
7. Cartwright D.P. Br. J. Anaesth. 71:1993;918-919.
8. Hunter J.M. N. Engl. J. Med. 332:1995;1691-1699.
9. Speight T.M., Avery G.S. Drugs. 4:1972;163-226.
10. King H. J. Chem. Soc. 1935;1381-1389.
11. Griffith H.R., Johnson G.E. Anaesthesiology. 3:1942;418-420.
12. Quevauviller M.A., Laine M.F. Ann. Pharm. Fr. 18:1960;678-680.
13. Baird W.L.M., Reid A.M. Br. J. Anaesth. 39:1967;775-780.
14. Buckett W.R., Hewett C.L., Savage D.S. J. Med. Chem. 16:1973;1116-1124.
15. Barankay A. Arzneim.-Forsch. Drug Res. 30:1980;386-389.
16. Bowman W.C., Webb S.N. J. Pharm. Pharmacol. 24:1972;762-772.
17. Phillipsborn W.v., Schmid H., Karrer P. Helv. Chim. Acta. 39:1956;913-922.
18. Bowman W.C., Szenohradszky J., Marosi Gy., Toth I. Arzneim-Forsch. Drug Res. 30:(I):1980;389-393.
19. Agoston S., Richardson F.J. Clin. Anaesthesiol. 3:1985;361-369.
20. Kárpati E., Biró K. Arzneim-Forsch. Drug Res. 30:1980;346-354.
21. Alyautdin R.N., Buyanov V.V., Fisenko V.P., Lemina E.Ju., Muratov V.K., Somoilov D.N., Shorr V.A. Arzeim-Forsch. Drug Res. 30:1980;355-357.
22. Mirakhur R.K. Drugs. 44:1992;182-199.
23. Hewett C.L., Savage D.S. J. Chem. Soc. Sect. C. 1966;484-488.
24. Numazava M., Nagaoko M. J. Org. Chem. 47:1982;4024-4029.
25. Schmitt J., Panhouse J.J., Hallot A., Cornu P.J., Comoy P., Pluchet H. Bull. Soc. Chim. France. 1963;807-815.
26. Muir A.W., Houston J., Green K.L., Marshall R.J., Bowman W.C., Marshall I.G. Br. J. Anaesth. 63:1989;400-410.
27. Ginsborg B., Warriner J. Br. J. Pharmacol. Chemother. 15:1960;410-411.
28. Arunlakshana O., Schild H.O. Br. J. Pharmacol. Chemother. 14:1959;48-58.